Our lead product candidate, AVB-500, is an ultra-high affinity decoy protein that starves the GAS6/AXL signaling pathway.

AVB-500 is an important driver of cell migration and invasion in cancer and fibrosis, by capturing circulating and bound GAS6. In both ovarian cancer and IgA nephropathy, increased GAS6 expression has been demonstrated.